This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.
The drug MOVYMIA contains one active pharmaceutical ingredient (API):
1
|
UNII
10T9CSU89I - TERIPARATIDE
|
|
Teriparatide (rhPTH(1-34)) is the active fragment (1-34) of endogenous human parathyroid hormone. Teriparatide is a bone formation agent to treat osteoporosis. The skeletal effects of teriparatide depend upon the pattern of systemic exposure. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| H05AA02 | Teriparatide | H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05A Parathyroid hormones and analogues → H05AA Parathyroid hormones and analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1736995, 1737008, 1798274 |
| ES | Centro de información online de medicamentos de la AEMPS | 1161161003 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 405663, 428393, 590598 |
| FR | Base de données publique des médicaments | 67114096 |
| GB | Medicines & Healthcare Products Regulatory Agency | 377531, 377534 |
| IE | Health Products Regulatory Authority | 88997, 88998 |
| IT | Agenzia del Farmaco | 045256017, 045256029, 045256031 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1081998, 1081999, 1088110 |
| NL | Z-Index G-Standaard, PRK | 198803, 198811 |
| PL | Rejestru Produktów Leczniczych | 100384003 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W66024001, W66024002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.